More articles from INTEGRATED Session: Endocrine/Neuroendocrine

You have access
Tracer kinetic analysis of ⁶⁸Ga-DOTATATE and ⁶⁸Ga-DOTATOC in neuroendocrine tumours
Mark Lubberink, Mattias Sandstrom, Jens Sörensen, Dan Granberg, Ulrike Garske-Román, Hans Lundqvist, Barbro Eriksson, Anders Sundin and Irina Velikyan

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 200;
You have access
[123I]Iodometomidate imaging in adrenocortical carcinoma: Evaluation of 58 patients
Michael Kreissl, Stefanie Hahner, Martin Fassnacht, Heribert Haenscheid, Frederik Verburg, Christopher Reiners, Andreas Buck, Bruno Allolio and Andreas Schirbel

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 195;
You have access
Utility of 18F-FDG PET-CT in pediatric neuroblastoma: Comparison with 131I-MIBG scintigraphy
Rakesh Kumar, Varun Dhull, Punit Sharma, Sandeep Agarwala, Sameer Bakhshi, Chandrasekhar Bal, Veereshwar Bhatnagar and Arun Malhotra

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 199;
You have access
18F-FDG PET use in the management of adrenocortical carcinoma
Satoshi Takeuchi, Aparna Balachandran, Mouhammed Habra, Alexandria Phan, Homer Macapinlac and Hubert Chuang

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 198;
You have access
Can molecular response after peptide receptor radionuclide therapy predict the overall and progression-free survival?
Harshad Kulkarni and Richard Baum

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 197;
You have access
Survival after somatostatin-based radiopeptide therapy with [⁹⁰Y-DOTA]-TOC and [⁹⁰Y-DOTA]-TOC plus [¹⁷⁷Lu-DOTA]-TOC in metastasized gastrinoma
Rebecca Dumont, Daniela Seiler, Nicolas Marincek, Christoph Rochlitz, Jan Mueller-Brand, Helmut Maecke, Matthias Briel and Martin Walter

Journal of Nuclear Medicine May 1, 2013, 54 (supplement 2) 196;

Main menu

User menu

Search

More articles from INTEGRATED Session: Endocrine/Neuroendocrine